The FTS will be tracked via fluorescent imaging detection to evidence how and where the semaglutide distributes and localizes following oral ingestion in Sprague ... use of certain glucagon-like ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

SAN JOSE, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. ("Rani Therapeutics” or "Rani”) (Nasdaq: ...

The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

Structure Therapeutics, Inc. Sponsored ADR ( (GPCR) ) has released its Q3 earnings. Here is a breakdown of the information Structure ...

Core focus on obesity includes exploratory co-administration BMT-801 study and two novel development drug candidatesPhase 2 BMT-801 clinical study with MC4R agonist bremelanotide plus GLP-1/GIP dual ...

The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September, and according to ...

“The ACCESS and ACCESS II studies are designed to generate a comprehensive data set that we believe will provide additional insights into the differentiated profile of GSBR-1290 as a potential best-in ...

AstraZeneca PLC aims for $80 billion revenue by 2030 through strong growth in oncology, biopharmaceuticals, and rare diseases ...

There’s been talk of GLP-1 and semaglutide drugs ... I’m taking my chances. Finasteride (an oral medication known as Propecia ...